Lettmann Jason
Insider CIK 1688269 · RARX Director, 10% owner · ALXO Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2026-08-17 | 2026-08-18 | 2,230 | $1.93 | $4.3K | 294,379 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2026-08-17 | 2026-08-18 | 2,230 | $1.93 | $4.3K | 294,379 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2026-03-19 | 2026-03-23 | 12,311 | $2.17 | $26.7K | 293,609 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | F Tax w/h | 2026-02-17 | 2026-02-19 | 2,201 | $2.27 | $5.0K | 305,920 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-26 | 2026-01-28 | 912,000 | — | $0 | 912,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-10-14 | 2025-10-16 | 597,500 | — | $0 | 597,500 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2025-09-17 | 2025-09-18 | 71,163 | $1.08 | $76.9K | 305,121 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2025-09-16 | 2025-09-18 | 21,070 | $1.07 | $22.5K | 233,958 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2025-08-15 | 2025-08-19 | 2,382 | $0.64 | $1.5K | 212,888 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award | 2025-03-14 | 2025-03-18 | 42,000 | — | $0 | 212,270 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2025-02-19 | 2025-02-21 | 2,159 | $1.15 | $2.5K | 170,270 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 478,000 | — | $0 | 478,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-12-02 | 2024-12-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | F Tax w/h | 2024-08-14 | 2024-08-16 | 2,191 | $2.58 | $5.7K | 169,429 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2024-03-14 | 2024-03-18 | 4,400 | $11.31 | $49.8K | 171,620 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-02-14 | 2024-02-16 | 190,000 | — | $0 | 190,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award | 2024-02-14 | 2024-02-16 | 60,000 | — | $0 | 167,220 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2023-09-08 | 2023-09-12 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 2,196 | $28.37 | $62.3K | 2,099,095 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 299 | $28.37 | $8.5K | 286,197 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 1,329 | $29.60 | $39.3K | 2,097,766 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 1,296 | $27.49 | $35.6K | 286,496 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 286,496 | $27.49 | $7.88M | 2,101,291 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 2,339 | $26.48 | $61.9K | 287,792 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 17,169 | $26.48 | $454.6K | 2,110,800 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 1,627 | $25.29 | $41.1K | 290,131 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 11,945 | $25.29 | $302.1K | 2,127,969 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 60 | $30.23 | $1.8K | 285,956 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 181 | $29.60 | $5.4K | 286,016 | SEC↗ |
| ALXO | S Sale | 2021-12-13 | 2021-12-15 | 440 | $30.23 | $13.3K | 2,097,326 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 12 | $32.16 | $386 | 291,758 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 88 | $32.16 | $2.8K | 2,139,914 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 2,172 | $31.55 | $68.5K | 291,770 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 15,942 | $31.55 | $503.0K | 2,140,002 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 967 | $30.77 | $29.8K | 293,942 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 7,093 | $30.77 | $218.3K | 2,155,944 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 1,911 | $32.73 | $62.5K | 294,909 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 14,028 | $32.73 | $459.1K | 2,163,037 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 5,751 | $32.06 | $184.4K | 296,820 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 42,203 | $32.06 | $1.35M | 2,177,065 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 1,560 | $31.08 | $48.5K | 302,571 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 11,452 | $31.08 | $355.9K | 2,219,268 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 1,531 | $33.80 | $51.7K | 2,230,720 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 208 | $33.80 | $7.0K | 304,131 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 35,836 | $33.23 | $1.19M | 2,232,251 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 4,883 | $33.23 | $162.3K | 304,339 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2021-06-11 | 2021-06-15 | 12,004 | — | $0 | 12,004 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 18,705 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 664,660 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 38,660 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 78,175 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 1,633,743 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 222,752 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 683,523 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 39,758 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 59,998 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 8,175 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 150,801 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 11,110 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 10,529 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 137,286 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 378,000 | $19.00 | $7.18M | 378,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 1,498,984 | — | $0 | 2,023,469 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 22,000 | $19.00 | $418.0K | 22,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 111,528 | — | $0 | 120,212 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 88,704 | — | $0 | 107,220 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 1,831,027 | — | $0 | 2,268,087 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 249,632 | — | $0 | 309,222 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2020-07-16 | 2020-07-17 | 24,009 | — | $0 | 24,009 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,798,914 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 481,503 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,664,071 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,408,439 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,533,875 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 9,744,916 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise deriv | 2016-10-31 | 2016-10-31 | 63,019 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 517,617 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2016-10-31 | 2016-10-31 | 340 | $13.00 | $4.4K | 79,821 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise | 2016-10-31 | 2016-10-31 | 63,019 | $0.07 | $4.4K | 80,161 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 15,633 | $13.00 | $203.2K | 4,066,503 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 114,752 | $13.00 | $1.49M | 4,050,870 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 263,538 | $13.00 | $3.43M | 3,936,118 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 68,786 | — | $0 | 3,672,580 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 504,839 | — | $0 | 3,603,794 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 73,945 | — | $0 | 3,098,955 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 542,702 | — | $0 | 3,025,010 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 486,919 | — | $0 | 2,482,308 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 523,438 | — | $0 | 1,995,389 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 1,392,130 | — | $0 | 1,471,951 | SEC↗ |